Drug intelligence / Profile preview

farnesol + xylitol

Development stage
Preclinical
Lead developer
Cure Parkinson's
Modality
Small Molecules
Administration
Topical, Oral
01

Overview

Farnesol + xylitol is a combination of two small molecules—farnesol, a sesquiterpene alcohol found in essential oils, and xylitol, a five-carbon sugar alcohol. This combination has been studied for its synergistic antibiofilm and antibacterial properties. Farnesol disrupts biofilm biomass and reduces bacterial viability by interfering with cell wall integrity and inhibiting superantigenic exotoxin production. Xylitol inhibits biofilm formation by disrupting glycocalyx production but minimally affects bacterial viability on its own. Together, they have shown enhanced efficacy against biofilms formed by pathogens such as Staphylococcus aureus and Enterococcus faecalis compared to either agent alone. The combination is being explored primarily for topical use in endodontics (root canal disinfection), dermatology (atopic dermatitis, rosacea), and potentially other skin conditions involving pathogenic biofilms[1][2][3][4][5].

Beyond the preview

Go deeper on farnesol + xylitol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on farnesol + xylitol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call